| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4204009 | Archivos de Bronconeumología | 2010 | 6 Pages |
Abstract
NSE levels might not be related with the stage of the disease. However, a low pre-treatment NSE level might be used in predicting good response to chemotherapy in patients with SCLC. The post-treatment serum NSE levels and the rate of change between pre- and post-treatment serum levels of NSE were not related with response to chemotherapy, progression-free survival, and overall survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Ahmet Emin Erbaycu, Ayriz Gunduz, Ozgur Batum, Zeynep Zeren Ucar, Fevziye Tuksavul, Salih Zeki Guclu,